|

Breaking: US will have effective Covid-19 vaccine by year-end – Fauci

Reuters reports that the leading US expert on infectious diseases, Dr. Anthony Fauci, predicted on Wednesday the country will meet its goal of a coronavirus vaccine by year's end and was unmoved by the prospect that China would get there first.

While there are no guarantees,

I feel good about the projected timetable,

Fauci told Reuters in an interview.

His comments follow promising early-stage data for the Moderna Inc's coronavirus vaccine, released on Tuesday, that was developed by scientists at the National Institute of Allergy and Infectious Diseases, which Fauci directs. 

Key notes

  • Infectious disease expert Fauci tells Reuters that u.s. will have effective coronavirus vaccine by year-end.
  • Fauci tells Reuters that Moderna's vaccine trial results were especially promising.
  • Fauci tells Reuters he does not think China will be first with a vaccine, at least not by much.

Fauci also said Moderna's results were especially promising because the vaccine appeared to offer the type of protection seen in a natural infection.

One of the things that you hope for is that your vaccine induces a response that's comparable to a natural infection, because theoretically, the best vaccine you could possibly ever get is a natural infection.

Reuters explained that "Moderna's candidate, which is set to enter the last stage of testing on July 27, is just one of more than a hundred vaccines in development globally, but only one of a few contenders that have earned millions of dollars in backing from Operation Warp Speed, the White House program that aims to deliver more than 300 million doses of a safe and effective COVID-19 vaccine by January."

Market implications

The market reaction to these comments from Fauci was muted considering the news dropped yesterday that there are promising signs with the vaccine following results of the test on 45 volunteers which revved-up and improved their immune systems.

Many experts see a safe and effective vaccine as the only way out of the pandemic that has infected millions and killed more than 575,000 people worldwide.

However, the statements made today should cement the improved risk-on themes in markets as we run into key economic data released today from China and ahead of US Retail Sales and the European Central Bank, likely playing second fiddle, however, to the EU summit this weekend. 

Inflation pressures will be the theme fs the vaccine rubber hits the road, a topic discussed in the following usual suspects earlier today:

Gold prices march-on above a key support structure as inflation expectations ramp-up

DXY meeting resistance in a bullish correction, bears lurking on risk-on themes gaining traction

Update from after the bell:

Author

More from FXStreet Team
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD clings to gains above 1.1700

Following the correction seen in the second half of the previous week, EUR/USD gains traction to start the new week and trades in positive territory above 1.1700. The US Dollar (USD) struggles to attract buyers as investors await Tuesday's GDP data ahead of the Christmas holiday. 

GBP/USD clings to recovery gains near 1.3400

GBP/USD is clinging to recovery gains near 1.3400 in early Europe on Monday. The pair capitalizes on an upbeat market mood and a steady US Dollar as traders digest the recent

 monetary policy decisions by the Fed and the BoE.

Gold hits new record-high above $4,400 as geopolitical tensions escalate

Gold trades at a fresh all-time-high above $4,400 Monday, rising more than 1.5% on a daily basis. The potential for a re-escalation of the tensions in the Middle East on news of Israel planning to attack Iran allows Gold to capitalize on safe-haven flows.

Bitcoin, Ethereum and Ripple eye breakout for fresh recovery

Bitcoin, Ethereum, and Ripple are approaching key technical levels at the time of writing on Monday as the broader crypto market stabilizes. Market participants are closely watching whether BTC, ETH, and XRP can sustain breakouts and achieve decisive daily closes above nearby resistance levels, which could signal the start of a short-term recovery.

Ten questions that matter going into 2026

2026 may be less about a neat “base case” and more about a regime shift—the market can reprice what matters most (growth, inflation, fiscal, geopolitics, concentration). The biggest trap is false comfort: the same trades can look defensive… right up until they become crowded.

Hyperliquid price forecast: Bullish interest builds amid user recovery

Hyperliquid (HYPE) trades at $25 at press time on Monday, holding the 3% gains from the previous day. The perpetual exchange sees a recovery in active users, while weekly fees collected decline to the lowest level so far this month.